Modification of the release characteristics of estradiol encapsulated in PLGA particles via surface coating

Therapeutic Delivery

Volumn 3, Issue 2, 2012, Pages 209-226

  Enayati, Marjan ^a   Stride, Eleanor ^a   Edirisinghe, Mohan ^a   Bonfield, William ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Range of drug concentration in human blood; which is effective without having toxic effects

Indexed keywords

CHITOSAN; ESTRADIOL; GELATIN; POLYGLACTIN;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; IN VITRO STUDY; PARTICLE SIZE; PRIORITY JOURNAL;

EID: 84857148255     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.11.154     Document Type: Article

References (45)

1. Cohen S, Yoshioka T, Lucarelli M, Hwang LH, Langer R. Controlled delivery systems for proteins based on PLGA microspheres. Pharm. Res. 8, 713-720 (1991).
2. Park TG, Lee HY, Nam YS. A new preparation method for protein loaded poly(d,l-lactic-co-glycolic acid) microspheres and protein release mechanism study. J. Control. Release 55, 181-191 (1998). (Pubitemid 28477609)
3. Herrmann J, Bodmeier R. The effect of particle microstructure on the somatostatin release from poly(lactide) microspheres prepared by a W/O/W solvent evaporation method. J. Control. Release 36, 63-71 (1995).
4. Lewis AL, Illum L. Formulation strategies for sustained release of proteins. Therapeutic Delivery 1(3), 457-479 (2010)
5. Wilson B, Samanta MK, Muthu MS, Vinothapooshan V. Design and evaluation of chitosan nanoparticles as novel drug carrier for the delivery of rivastigmine to treat Alzheimer's disease. Therapeutic Delivery 2, 599-609 (2011).
6. Zhang JX, Chen D, Wang SJ, Zhu KJ. Optimizing double emulsion process to decrease the burst release of protein from biodegradable polymer microspheres, J. Microencapsul. 22(4), 413-422 (2005). (Pubitemid 41581879)
7. O'Donnell PB, Mcginity JW, Preparation of microspheres by the solvent evaporation technique. Adv. Drug Deliv. Rev. 28, 25-42 (1997). (Pubitemid 27497672)
8. Pitt CG. The controlled parenteral delivery of polypeptides and proteins. Int. J. Pharm. 59, 173-196 (1990). (Pubitemid 20146149)
9. Jeong KJ, Kohane DS. Surface modification and drug delivery for biointegration, Therapeutic Delivery 2(6,) 737-752 (2011).
10. Ravivarapu HB, Lee H, DeLuca PP. Enhancing initial release of peptide from poly(d,l-lactide-co-glycolide) (PLGA) microspheres by addition of a porosigen and increasing drug load. Pharm. Dev. Technol. 5, 287-296 (2000). (Pubitemid 30247109)
11. Körber M, Bodmeier R. Development of an in situ forming PLGA drug delivery system: I. Characterization of a non-aqueous protein precipitation. Eur J. Pharm. Sci. 35, 283-292 (2008).
12. Burton KW, Shameem M, Thanoo BC, Deluca PP. Extended release peptide delivery systems through the use of PLGA microsphere combinations. J. Biomater. Sci. 11, 715-729 (2000).
13. Aggarwal A, Kaur S, Tiwary AK, Gupta S. Chitosan microspheres prepared by an aqueous process: release of indomethacin. J. Microencapsul. 18, 819-823 (2001). (Pubitemid 32998326)
14. Chiou SH, Wu WT, Huang YY, Chung TW. Effects of the characteristics of chitosan on controlling drug release of chitosan coated PLLA microspheres. J. Microencapsul. 18, 613-625 (2001).
15. Pazol K, Kaplan JR, Abbott D, Appt SE, Wilson ME. Practical measurement of total and bioavailable estradiol in female macaques. Clin. Chim. Acta 340 (1-2), 117-126 (2004). (Pubitemid 38167515)
16. Variankaval NE, Jacob KI, Dinh SM, polymorphism of 17-b estradiol in a transdermal drug delivery system. J. Mater. Sci. Mater. Med. 13, 271-280 (2002). (Pubitemid 34234034)
17. Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MNV. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J. Control. Release 119, 77-85, (2007). (Pubitemid 46561546)
18. Valles S, Dolz-Gaiton P, Gambini J et al. Estradiol or genistein prevent Alzheimer's disease-associated inflammation correlating with an increase PPAR gamma expression in cultured astrocytes. Brain Res. 1312, 138-144(2010).
19. Weidenauer U, Bodmer D, Kissel T. Microencapsulation of hydrophilic drug substance using biodegradable polyesters. Part I. Evaluation of different techniques for the encapsulation of pamidronate disodium salt. J. Microencapsul. 20, 509-524 (2003). (Pubitemid 36805897)
20. Yang YY, Chung TS, Bai XL, Chan WK, Effect of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion method. Chem. Eng. Sci. 55, 2223-2236 (2000).
21. Mitragotri S, Lahann J. Physical approaches to biomaterial design. Nat. Mater. 8, 15-23 (2009).
22. Xie J, Lim LK, Phua Y, Hua J, Wang CH. Electrohydrodynamic atomization for biodegradable polymeric particle production. J. Colloid Interface Sci. 302, 103-112 (2006). (Pubitemid 44269355)
23. Wang K, Stark JPW. Deposition of colloidal gold nanoparticles by fully pulsed-voltage-controlled electrohydrodynamic atomisation. J. Nanopart. Res. 12, 707-711 (2010).
24. Enayati M, Ahmad Z, Stride E, Edirisinghe M. One-step electrohydrodynamic production of drug-loaded micro- and nanoparticles. J. R. Soc. Interface 7, 667-675 (2009).
25. Swain BP, Pattanayak DK. Simulated body fluid (SBF) adsorption onto a-SiC:H thin films deposited by hot wire chemical vapor deposition (HWCVD), Mater. Lett. 62, 3484-3486 (2008).
26. Oyane A, Kim HM, Furuya T, Kokubo T, Miyazaki T, Nakamura T. Preparation and assessment of revised simulated body fluid. J. Biomed. Mater. Res. 65A, 188-195 (2003). (Pubitemid 37521424)
27. Iglesias RB, Lorenzo CA, Concheiro A. Controlled release of estradiol solubilized in carbopol/surfactant aggregates. J. Control. Release 93, 319-330 (2003). (Pubitemid 37485954)
28. Birnbaum DT, Kosmala JD, Henthorn DB, Brannon-Peppas L. Controlled release of b-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release. J. Control. Release 65, 375-387 (2000). (Pubitemid 30122940)
29. Hartman RPA, Brunner DJ, Camelot DMA, Marijnissen JCM, Scarlett B. Jet break-up in electrohydrodynamic atomization in the cone-jet mode. J. Aerosol Sci. 31, 65-95 (2000).
30. Cloupeau M, Prunet Foch B. Electrostatic spraying of liquids: main functioning modes. J. Electrostat. 25, 165-184 (1990).
31. Monsky WL, Fukumura D, Gohongi T et al. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res. 59, 4129-4135 (1999). (Pubitemid 29393588)
32. Oyewumi MO, Mumper RJ. Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticles. Int. J. Pharm. 251(1-2), 85-97 (2003). (Pubitemid 36071463)
33. Musante CJ, Schroeter JD, Rosati JA, Crowder TM, Hickey AJ, Martonen TB. Factors affecting the deposition of inhaled porous drug particles. J. Pharm Sci. 91, 1590-1600 (2002). (Pubitemid 34680222)
34. Edwards DA, Hanes J, Caponetti G et al. Large porous particles for pulmonary drug delivery. Science 276, 1868-1871 (1997). (Pubitemid 27443665)
35. Jayasinghe SN, Edirisinghe MJ. Effect of viscosity on the size of relics produced by electrostatic atomization. J. Aerosol. Sci. 33, 1379-1388 (2002).
36. Xu Y, Hanna MA. Electrospray encapsulation of water-soluble protein with polylactide effects of formulations on morphology, encapsulation efficiency and release profile of particles. Int. J. Pharm. 320, 30-36 (2006). (Pubitemid 44128701)
37. Gaumet M, Vargas A, Gurny R, Delie F. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur. J. Pharm. Biopharm. 69 (1), 1-9 (2008). (Pubitemid 351467152)
38. Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 28, 5-24 (1997). (Pubitemid 27497671)
39. Wu Y, Yang W, Wang C, Hu J, Fu S. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int. J. Pharm. 295 (1-2), 235-245 (2005). (Pubitemid 40558806)
40. Nam HY, Kim DJ, Lim HJ et al. Reduced burst release from ePTFE grafts: a new coating method for controlled drug release. Bull. Korean Chem. Soc. 29 (2), 422-426 (2008).
41. Ahmed AR, Elkharraz K, Irfan M, Bodmeier R. Reduction in burst release after coating poly(d,l-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer. Pharm. Dev. Technol. 17(1), 66-72 (2012).
42. Xiang Z, Sarazin P,Favis BD. Controlling burst and final drug release times from porous polylactide devices derived from co-continuous polymer blends. Biomacromolecules 10, 2053-2066, (2009).
43. Young S, Wong M, Tabata Y, Mikos AG. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J. Control. Release 109 256-274 (2005). (Pubitemid 41737269)
44. Curcio M, Spizzirri UG, Iemma F et al. Grafted thermo-responsive gelatin microspheres as delivery systems in triggered drug release. Eur. J. Pharm. Biopharm. 76, 48-55 (2010).
45. Patel ZS, Yamamoto M, Ueda H, Tabata Y, Mikos AG. Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. Acta Biomaterialia 4, 1126-1138 (2008).